PHARMAC are experiencing supply issues with a number of oral contraceptives.
Pfizer New Zealand (Pfizer) wishes to advise that NORIMIN 28 Day tablets and BREVINOR-1® 28 Day tablets are currently out of stock.
In addition, stock of the temporary BREVINOR® 28 Day (0.5mg norethisterone / 0.035mg ethinylestradiol) introduced to maintain supply for patients during the initial shortage of NORIMIN 28 Day will shortly be exhausted.
Pfizer has experienced unforeseen long-term disruption to supply and, despite all efforts by Pfizer to mitigate the situation, we now anticipate being unable to re-supply these products until February 2021. Pfizer will advise should there be any change to this timeline.
In the interest of patients having continued access to appropriate contraceptive protection, it may be prudent to review the alternative options that are available to them at the earliest convenience.
Please refer to the NORIMIN 28 Day and BREVINOR-1® 28 Day Data Sheets and Consumer Medicines Information documents in www.medsafe.govt.nz for the complete product information.
For any medical or stock queries please contact Pfizer on 0800 736 363.
Please report any suspected adverse events via email to Pfizer Drug Safety at AUS.AEReporting@pfizer.com. Alternatively, suspected adverse events may be reported to the Centre for Adverse Reactions Monitoring (CARM) in Dunedin online at https://nzphvc.otago.ac.nz/reporting or by email to firstname.lastname@example.org.